Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
87.50
+0.90 (1.04%)
Jul 30, 2026, 1:09 PM CST

Syngen Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,0672,1362,0141,8371,9311,471
Revenue Growth
1.74%6.10%9.60%-4.84%31.22%12.19%
Gross Profit
687.05723.59723.94643.92688.15528.34
Operating Income
296.08326.98303.3302.86362.38281.48
Net Income
243.83271.59240.21274.83321.24237.77
Earnings Per Share
8.9910.018.8510.1311.848.76
EPS Growth
1.02%13.11%-12.64%-14.44%35.16%10.33%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan
2,0211,8701,6991,7701,298
Others
115.7144.05112.8688.5476.07
Total
2,1362,0141,8371,9311,471

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
319.87275.47341.93366.89246.05314.8
Total Debt
165.63225.19397.93538.49600.78236.08
Net Cash (Debt)
154.2450.27-56-171.6-354.7378.72
Net Cash Growth
------54.53%
Net Cash Per Share
5.681.85-2.06-6.33-13.072.90

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
374.32319.48348.04415.13277.48336.5
Capital Expenditures
-49.98-63.56-60.21-91.9-584.27-61.67
Free Cash Flow
324.34255.92287.83323.23-306.79274.83
Free Cash Flow Growth
4.46%-11.09%-10.95%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
33.23%33.87%35.95%35.05%35.64%35.91%
Operating Margin
14.32%15.30%15.06%16.48%18.77%19.13%
Pretax Margin
14.56%15.67%14.88%18.17%20.53%20.08%
Profit Margin
11.79%12.71%11.93%14.96%16.64%16.16%
FCF Margin
15.69%11.98%14.29%17.59%-15.89%18.68%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
5.0005.0005.0005.0005.0004.000
Dividend Per Share Growth
0%0%0%0%25.00%14.29%
Dividend Yield
5.68%4.55%4.32%3.72%3.60%4.26%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
10.4011.5814.3314.9913.6712.88
Forward PE
-14.1214.1213.6314.4812.56
P/FCF Ratio
10.3512.2811.9612.74-11.14
PS Ratio
1.141.471.712.242.272.08